nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Vincristine—lymphatic system cancer	0.228	0.384	CbGbCtD
Levetiracetam—ABCC2—Methotrexate—lymphatic system cancer	0.138	0.233	CbGbCtD
Levetiracetam—ABCB1—Mitoxantrone—lymphatic system cancer	0.108	0.182	CbGbCtD
Levetiracetam—ABCB1—Vincristine—lymphatic system cancer	0.0743	0.125	CbGbCtD
Levetiracetam—ABCB1—Methotrexate—lymphatic system cancer	0.045	0.0758	CbGbCtD
Levetiracetam—Feeling abnormal—Teniposide—lymphatic system cancer	0.00111	0.00273	CcSEcCtD
Levetiracetam—Stomatitis—Vincristine—lymphatic system cancer	0.00111	0.00272	CcSEcCtD
Levetiracetam—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00111	0.00271	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.0011	0.00271	CcSEcCtD
Levetiracetam—Skin discolouration—Methotrexate—lymphatic system cancer	0.00109	0.00268	CcSEcCtD
Levetiracetam—Nausea—Mechlorethamine—lymphatic system cancer	0.00109	0.00267	CcSEcCtD
Levetiracetam—Alopecia—Bleomycin—lymphatic system cancer	0.00108	0.00265	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00108	0.00265	CcSEcCtD
Levetiracetam—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00108	0.00265	CcSEcCtD
Levetiracetam—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00107	0.00264	CcSEcCtD
Levetiracetam—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00107	0.00264	CcSEcCtD
Levetiracetam—Abdominal pain—Teniposide—lymphatic system cancer	0.00107	0.00262	CcSEcCtD
Levetiracetam—Body temperature increased—Teniposide—lymphatic system cancer	0.00107	0.00262	CcSEcCtD
Levetiracetam—Paraesthesia—Fludarabine—lymphatic system cancer	0.00106	0.00261	CcSEcCtD
Levetiracetam—Hallucination—Carmustine—lymphatic system cancer	0.00106	0.00261	CcSEcCtD
Levetiracetam—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00105	0.00258	CcSEcCtD
Levetiracetam—Dyspepsia—Fludarabine—lymphatic system cancer	0.00104	0.00256	CcSEcCtD
Levetiracetam—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00104	0.00255	CcSEcCtD
Levetiracetam—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00103	0.00253	CcSEcCtD
Levetiracetam—Decreased appetite—Fludarabine—lymphatic system cancer	0.00103	0.00253	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00102	0.00251	CcSEcCtD
Levetiracetam—Fatigue—Fludarabine—lymphatic system cancer	0.00102	0.00251	CcSEcCtD
Levetiracetam—Hallucination—Vincristine—lymphatic system cancer	0.00101	0.00249	CcSEcCtD
Levetiracetam—Constipation—Fludarabine—lymphatic system cancer	0.00101	0.00249	CcSEcCtD
Levetiracetam—Pain—Fludarabine—lymphatic system cancer	0.00101	0.00249	CcSEcCtD
Levetiracetam—Respiratory failure—Methotrexate—lymphatic system cancer	0.001	0.00246	CcSEcCtD
Levetiracetam—Connective tissue disorder—Vincristine—lymphatic system cancer	0.001	0.00246	CcSEcCtD
Levetiracetam—Eye disorder—Carmustine—lymphatic system cancer	0.000997	0.00245	CcSEcCtD
Levetiracetam—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000995	0.00244	CcSEcCtD
Levetiracetam—Hypersensitivity—Teniposide—lymphatic system cancer	0.000993	0.00244	CcSEcCtD
Levetiracetam—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000992	0.00244	CcSEcCtD
Levetiracetam—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000985	0.00242	CcSEcCtD
Levetiracetam—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000976	0.0024	CcSEcCtD
Levetiracetam—Asthenia—Teniposide—lymphatic system cancer	0.000967	0.00237	CcSEcCtD
Levetiracetam—Pruritus—Teniposide—lymphatic system cancer	0.000954	0.00234	CcSEcCtD
Levetiracetam—Leukopenia—Bleomycin—lymphatic system cancer	0.000953	0.00234	CcSEcCtD
Levetiracetam—Alopecia—Carmustine—lymphatic system cancer	0.000943	0.00232	CcSEcCtD
Levetiracetam—Body temperature increased—Fludarabine—lymphatic system cancer	0.000937	0.0023	CcSEcCtD
Levetiracetam—Mental disorder—Carmustine—lymphatic system cancer	0.000935	0.0023	CcSEcCtD
Levetiracetam—Malnutrition—Carmustine—lymphatic system cancer	0.000929	0.00228	CcSEcCtD
Levetiracetam—Cough—Bleomycin—lymphatic system cancer	0.000929	0.00228	CcSEcCtD
Levetiracetam—Diarrhoea—Teniposide—lymphatic system cancer	0.000922	0.00226	CcSEcCtD
Levetiracetam—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000918	0.00225	CcSEcCtD
Levetiracetam—Chest pain—Bleomycin—lymphatic system cancer	0.000906	0.00222	CcSEcCtD
Levetiracetam—Myalgia—Bleomycin—lymphatic system cancer	0.000906	0.00222	CcSEcCtD
Levetiracetam—Alopecia—Vincristine—lymphatic system cancer	0.0009	0.00221	CcSEcCtD
Levetiracetam—Back pain—Carmustine—lymphatic system cancer	0.000899	0.00221	CcSEcCtD
Levetiracetam—Mental disorder—Vincristine—lymphatic system cancer	0.000893	0.00219	CcSEcCtD
Levetiracetam—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00089	0.00219	CcSEcCtD
Levetiracetam—Ecchymosis—Methotrexate—lymphatic system cancer	0.00089	0.00219	CcSEcCtD
Levetiracetam—Alopecia—Mitoxantrone—lymphatic system cancer	0.000877	0.00215	CcSEcCtD
Levetiracetam—Confusional state—Bleomycin—lymphatic system cancer	0.000876	0.00215	CcSEcCtD
Levetiracetam—Vision blurred—Carmustine—lymphatic system cancer	0.000876	0.00215	CcSEcCtD
Levetiracetam—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000873	0.00214	CcSEcCtD
Levetiracetam—Tremor—Carmustine—lymphatic system cancer	0.00087	0.00214	CcSEcCtD
Levetiracetam—Infection—Bleomycin—lymphatic system cancer	0.000863	0.00212	CcSEcCtD
Levetiracetam—Back pain—Vincristine—lymphatic system cancer	0.000858	0.00211	CcSEcCtD
Levetiracetam—Vomiting—Teniposide—lymphatic system cancer	0.000857	0.0021	CcSEcCtD
Levetiracetam—Agitation—Carmustine—lymphatic system cancer	0.000854	0.0021	CcSEcCtD
Levetiracetam—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00085	0.00209	CcSEcCtD
Levetiracetam—Asthenia—Fludarabine—lymphatic system cancer	0.00085	0.00209	CcSEcCtD
Levetiracetam—Rash—Teniposide—lymphatic system cancer	0.00085	0.00209	CcSEcCtD
Levetiracetam—Dermatitis—Teniposide—lymphatic system cancer	0.000849	0.00209	CcSEcCtD
Levetiracetam—Headache—Teniposide—lymphatic system cancer	0.000844	0.00207	CcSEcCtD
Levetiracetam—Pruritus—Fludarabine—lymphatic system cancer	0.000838	0.00206	CcSEcCtD
Levetiracetam—Back pain—Mitoxantrone—lymphatic system cancer	0.000835	0.00205	CcSEcCtD
Levetiracetam—Leukopenia—Carmustine—lymphatic system cancer	0.000832	0.00204	CcSEcCtD
Levetiracetam—Anorexia—Bleomycin—lymphatic system cancer	0.000828	0.00203	CcSEcCtD
Levetiracetam—Agitation—Vincristine—lymphatic system cancer	0.000815	0.002	CcSEcCtD
Levetiracetam—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000814	0.002	CcSEcCtD
Levetiracetam—Diarrhoea—Fludarabine—lymphatic system cancer	0.000811	0.00199	CcSEcCtD
Levetiracetam—Convulsion—Carmustine—lymphatic system cancer	0.000805	0.00198	CcSEcCtD
Levetiracetam—Nausea—Teniposide—lymphatic system cancer	0.000801	0.00197	CcSEcCtD
Levetiracetam—Vertigo—Vincristine—lymphatic system cancer	0.000797	0.00196	CcSEcCtD
Levetiracetam—Hepatic failure—Methotrexate—lymphatic system cancer	0.000795	0.00195	CcSEcCtD
Levetiracetam—Leukopenia—Vincristine—lymphatic system cancer	0.000794	0.00195	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000791	0.00194	CcSEcCtD
Levetiracetam—Chest pain—Carmustine—lymphatic system cancer	0.000791	0.00194	CcSEcCtD
Levetiracetam—Myalgia—Carmustine—lymphatic system cancer	0.000791	0.00194	CcSEcCtD
Levetiracetam—Anxiety—Carmustine—lymphatic system cancer	0.000788	0.00194	CcSEcCtD
Levetiracetam—Paraesthesia—Bleomycin—lymphatic system cancer	0.00078	0.00192	CcSEcCtD
Levetiracetam—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000773	0.0019	CcSEcCtD
Levetiracetam—Convulsion—Vincristine—lymphatic system cancer	0.000768	0.00189	CcSEcCtD
Levetiracetam—Confusional state—Carmustine—lymphatic system cancer	0.000764	0.00188	CcSEcCtD
Levetiracetam—Decreased appetite—Bleomycin—lymphatic system cancer	0.000755	0.00185	CcSEcCtD
Levetiracetam—Myalgia—Vincristine—lymphatic system cancer	0.000755	0.00185	CcSEcCtD
Levetiracetam—Cough—Mitoxantrone—lymphatic system cancer	0.000754	0.00185	CcSEcCtD
Levetiracetam—Infection—Carmustine—lymphatic system cancer	0.000753	0.00185	CcSEcCtD
Levetiracetam—Vomiting—Fludarabine—lymphatic system cancer	0.000753	0.00185	CcSEcCtD
Levetiracetam—Convulsion—Mitoxantrone—lymphatic system cancer	0.000748	0.00184	CcSEcCtD
Levetiracetam—Rash—Fludarabine—lymphatic system cancer	0.000747	0.00183	CcSEcCtD
Levetiracetam—Dermatitis—Fludarabine—lymphatic system cancer	0.000746	0.00183	CcSEcCtD
Levetiracetam—Pain—Bleomycin—lymphatic system cancer	0.000743	0.00182	CcSEcCtD
Levetiracetam—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000742	0.00182	CcSEcCtD
Levetiracetam—Headache—Fludarabine—lymphatic system cancer	0.000742	0.00182	CcSEcCtD
Levetiracetam—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000735	0.00181	CcSEcCtD
Levetiracetam—Myalgia—Mitoxantrone—lymphatic system cancer	0.000735	0.00181	CcSEcCtD
Levetiracetam—Chest pain—Mitoxantrone—lymphatic system cancer	0.000735	0.00181	CcSEcCtD
Levetiracetam—Anxiety—Mitoxantrone—lymphatic system cancer	0.000733	0.0018	CcSEcCtD
Levetiracetam—Lethargy—Methotrexate—lymphatic system cancer	0.000729	0.00179	CcSEcCtD
Levetiracetam—Anorexia—Carmustine—lymphatic system cancer	0.000723	0.00177	CcSEcCtD
Levetiracetam—Infection—Vincristine—lymphatic system cancer	0.000719	0.00177	CcSEcCtD
Levetiracetam—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000716	0.00176	CcSEcCtD
Levetiracetam—Confusional state—Mitoxantrone—lymphatic system cancer	0.000711	0.00175	CcSEcCtD
Levetiracetam—Nervous system disorder—Vincristine—lymphatic system cancer	0.00071	0.00174	CcSEcCtD
Levetiracetam—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000709	0.00174	CcSEcCtD
Levetiracetam—Nausea—Fludarabine—lymphatic system cancer	0.000704	0.00173	CcSEcCtD
Levetiracetam—Infection—Mitoxantrone—lymphatic system cancer	0.0007	0.00172	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000691	0.0017	CcSEcCtD
Levetiracetam—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00069	0.00169	CcSEcCtD
Levetiracetam—Anorexia—Vincristine—lymphatic system cancer	0.00069	0.00169	CcSEcCtD
Levetiracetam—Body temperature increased—Bleomycin—lymphatic system cancer	0.000687	0.00169	CcSEcCtD
Levetiracetam—Insomnia—Carmustine—lymphatic system cancer	0.000686	0.00168	CcSEcCtD
Levetiracetam—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000685	0.00168	CcSEcCtD
Levetiracetam—Irritability—Methotrexate—lymphatic system cancer	0.000682	0.00167	CcSEcCtD
Levetiracetam—Paraesthesia—Carmustine—lymphatic system cancer	0.000681	0.00167	CcSEcCtD
Levetiracetam—Mood swings—Methotrexate—lymphatic system cancer	0.000677	0.00166	CcSEcCtD
Levetiracetam—Somnolence—Carmustine—lymphatic system cancer	0.000674	0.00166	CcSEcCtD
Levetiracetam—Anorexia—Mitoxantrone—lymphatic system cancer	0.000672	0.00165	CcSEcCtD
Levetiracetam—Ataxia—Methotrexate—lymphatic system cancer	0.000672	0.00165	CcSEcCtD
Levetiracetam—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00066	0.00162	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000659	0.00162	CcSEcCtD
Levetiracetam—Decreased appetite—Carmustine—lymphatic system cancer	0.000659	0.00162	CcSEcCtD
Levetiracetam—Insomnia—Vincristine—lymphatic system cancer	0.000655	0.00161	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000655	0.00161	CcSEcCtD
Levetiracetam—Paraesthesia—Vincristine—lymphatic system cancer	0.00065	0.0016	CcSEcCtD
Levetiracetam—Pain—Carmustine—lymphatic system cancer	0.000648	0.00159	CcSEcCtD
Levetiracetam—Constipation—Carmustine—lymphatic system cancer	0.000648	0.00159	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000643	0.00158	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000642	0.00158	CcSEcCtD
Levetiracetam—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00064	0.00157	CcSEcCtD
Levetiracetam—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000633	0.00155	CcSEcCtD
Levetiracetam—Decreased appetite—Vincristine—lymphatic system cancer	0.000629	0.00154	CcSEcCtD
Levetiracetam—Somnolence—Mitoxantrone—lymphatic system cancer	0.000627	0.00154	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000625	0.00153	CcSEcCtD
Levetiracetam—Feeling abnormal—Carmustine—lymphatic system cancer	0.000625	0.00153	CcSEcCtD
Levetiracetam—Fatigue—Vincristine—lymphatic system cancer	0.000624	0.00153	CcSEcCtD
Levetiracetam—Asthenia—Bleomycin—lymphatic system cancer	0.000623	0.00153	CcSEcCtD
Levetiracetam—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00062	0.00152	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00062	0.00152	CcSEcCtD
Levetiracetam—Pain—Vincristine—lymphatic system cancer	0.000619	0.00152	CcSEcCtD
Levetiracetam—Constipation—Vincristine—lymphatic system cancer	0.000619	0.00152	CcSEcCtD
Levetiracetam—Asthma—Methotrexate—lymphatic system cancer	0.000618	0.00152	CcSEcCtD
Levetiracetam—Pruritus—Bleomycin—lymphatic system cancer	0.000615	0.00151	CcSEcCtD
Levetiracetam—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000613	0.0015	CcSEcCtD
Levetiracetam—Eosinophilia—Methotrexate—lymphatic system cancer	0.000611	0.0015	CcSEcCtD
Levetiracetam—Fatigue—Mitoxantrone—lymphatic system cancer	0.000608	0.00149	CcSEcCtD
Levetiracetam—Pancreatitis—Methotrexate—lymphatic system cancer	0.000605	0.00149	CcSEcCtD
Levetiracetam—Pain—Mitoxantrone—lymphatic system cancer	0.000603	0.00148	CcSEcCtD
Levetiracetam—Constipation—Mitoxantrone—lymphatic system cancer	0.000603	0.00148	CcSEcCtD
Levetiracetam—Abdominal pain—Carmustine—lymphatic system cancer	0.000599	0.00147	CcSEcCtD
Levetiracetam—Body temperature increased—Carmustine—lymphatic system cancer	0.000599	0.00147	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000592	0.00145	CcSEcCtD
Levetiracetam—Pancytopenia—Methotrexate—lymphatic system cancer	0.000586	0.00144	CcSEcCtD
Levetiracetam—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000581	0.00143	CcSEcCtD
Levetiracetam—Neutropenia—Methotrexate—lymphatic system cancer	0.000577	0.00142	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000576	0.00142	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000574	0.00141	CcSEcCtD
Levetiracetam—Abdominal pain—Vincristine—lymphatic system cancer	0.000572	0.0014	CcSEcCtD
Levetiracetam—Body temperature increased—Vincristine—lymphatic system cancer	0.000572	0.0014	CcSEcCtD
Levetiracetam—Hypersensitivity—Carmustine—lymphatic system cancer	0.000559	0.00137	CcSEcCtD
Levetiracetam—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000557	0.00137	CcSEcCtD
Levetiracetam—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000557	0.00137	CcSEcCtD
Levetiracetam—Vomiting—Bleomycin—lymphatic system cancer	0.000552	0.00136	CcSEcCtD
Levetiracetam—Drowsiness—Methotrexate—lymphatic system cancer	0.000551	0.00135	CcSEcCtD
Levetiracetam—Infestation NOS—Methotrexate—lymphatic system cancer	0.000551	0.00135	CcSEcCtD
Levetiracetam—Infestation—Methotrexate—lymphatic system cancer	0.000551	0.00135	CcSEcCtD
Levetiracetam—Depression—Methotrexate—lymphatic system cancer	0.000549	0.00135	CcSEcCtD
Levetiracetam—Rash—Bleomycin—lymphatic system cancer	0.000548	0.00134	CcSEcCtD
Levetiracetam—Dermatitis—Bleomycin—lymphatic system cancer	0.000547	0.00134	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000546	0.00134	CcSEcCtD
Levetiracetam—Asthenia—Carmustine—lymphatic system cancer	0.000544	0.00134	CcSEcCtD
Levetiracetam—Stomatitis—Methotrexate—lymphatic system cancer	0.000537	0.00132	CcSEcCtD
Levetiracetam—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000535	0.00131	CcSEcCtD
Levetiracetam—Hypersensitivity—Vincristine—lymphatic system cancer	0.000533	0.00131	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000521	0.00128	CcSEcCtD
Levetiracetam—Epistaxis—Methotrexate—lymphatic system cancer	0.000519	0.00128	CcSEcCtD
Levetiracetam—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000519	0.00128	CcSEcCtD
Levetiracetam—Asthenia—Vincristine—lymphatic system cancer	0.000519	0.00128	CcSEcCtD
Levetiracetam—Diarrhoea—Carmustine—lymphatic system cancer	0.000519	0.00127	CcSEcCtD
Levetiracetam—Nausea—Bleomycin—lymphatic system cancer	0.000516	0.00127	CcSEcCtD
Levetiracetam—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000514	0.00126	CcSEcCtD
Levetiracetam—Asthenia—Mitoxantrone—lymphatic system cancer	0.000506	0.00124	CcSEcCtD
Levetiracetam—Dizziness—Carmustine—lymphatic system cancer	0.000501	0.00123	CcSEcCtD
Levetiracetam—Diarrhoea—Vincristine—lymphatic system cancer	0.000495	0.00122	CcSEcCtD
Levetiracetam—Hepatitis—Methotrexate—lymphatic system cancer	0.000494	0.00121	CcSEcCtD
Levetiracetam—Pharyngitis—Methotrexate—lymphatic system cancer	0.000491	0.0012	CcSEcCtD
Levetiracetam—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000482	0.00118	CcSEcCtD
Levetiracetam—Vomiting—Carmustine—lymphatic system cancer	0.000482	0.00118	CcSEcCtD
Levetiracetam—Dizziness—Vincristine—lymphatic system cancer	0.000479	0.00118	CcSEcCtD
Levetiracetam—Rash—Carmustine—lymphatic system cancer	0.000478	0.00117	CcSEcCtD
Levetiracetam—Dermatitis—Carmustine—lymphatic system cancer	0.000478	0.00117	CcSEcCtD
Levetiracetam—Headache—Carmustine—lymphatic system cancer	0.000475	0.00117	CcSEcCtD
Levetiracetam—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000467	0.00115	CcSEcCtD
Levetiracetam—Eye disorder—Methotrexate—lymphatic system cancer	0.000462	0.00113	CcSEcCtD
Levetiracetam—Vomiting—Vincristine—lymphatic system cancer	0.00046	0.00113	CcSEcCtD
Levetiracetam—Rash—Vincristine—lymphatic system cancer	0.000456	0.00112	CcSEcCtD
Levetiracetam—Dermatitis—Vincristine—lymphatic system cancer	0.000456	0.00112	CcSEcCtD
Levetiracetam—Headache—Vincristine—lymphatic system cancer	0.000453	0.00111	CcSEcCtD
Levetiracetam—Nausea—Carmustine—lymphatic system cancer	0.00045	0.00111	CcSEcCtD
Levetiracetam—Vomiting—Mitoxantrone—lymphatic system cancer	0.000448	0.0011	CcSEcCtD
Levetiracetam—Immune system disorder—Methotrexate—lymphatic system cancer	0.000446	0.0011	CcSEcCtD
Levetiracetam—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000445	0.00109	CcSEcCtD
Levetiracetam—Rash—Mitoxantrone—lymphatic system cancer	0.000444	0.00109	CcSEcCtD
Levetiracetam—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000444	0.00109	CcSEcCtD
Levetiracetam—Headache—Mitoxantrone—lymphatic system cancer	0.000442	0.00108	CcSEcCtD
Levetiracetam—Alopecia—Methotrexate—lymphatic system cancer	0.000437	0.00107	CcSEcCtD
Levetiracetam—Mental disorder—Methotrexate—lymphatic system cancer	0.000433	0.00106	CcSEcCtD
Levetiracetam—Malnutrition—Methotrexate—lymphatic system cancer	0.00043	0.00106	CcSEcCtD
Levetiracetam—Nausea—Vincristine—lymphatic system cancer	0.00043	0.00106	CcSEcCtD
Levetiracetam—Nausea—Mitoxantrone—lymphatic system cancer	0.000419	0.00103	CcSEcCtD
Levetiracetam—Back pain—Methotrexate—lymphatic system cancer	0.000416	0.00102	CcSEcCtD
Levetiracetam—Vision blurred—Methotrexate—lymphatic system cancer	0.000406	0.000996	CcSEcCtD
Levetiracetam—Vertigo—Methotrexate—lymphatic system cancer	0.000387	0.000949	CcSEcCtD
Levetiracetam—Leukopenia—Methotrexate—lymphatic system cancer	0.000385	0.000946	CcSEcCtD
Levetiracetam—Cough—Methotrexate—lymphatic system cancer	0.000375	0.000922	CcSEcCtD
Levetiracetam—Convulsion—Methotrexate—lymphatic system cancer	0.000373	0.000915	CcSEcCtD
Levetiracetam—Chest pain—Methotrexate—lymphatic system cancer	0.000366	0.0009	CcSEcCtD
Levetiracetam—Arthralgia—Methotrexate—lymphatic system cancer	0.000366	0.0009	CcSEcCtD
Levetiracetam—Myalgia—Methotrexate—lymphatic system cancer	0.000366	0.0009	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000364	0.000893	CcSEcCtD
Levetiracetam—Confusional state—Methotrexate—lymphatic system cancer	0.000354	0.00087	CcSEcCtD
Levetiracetam—Infection—Methotrexate—lymphatic system cancer	0.000349	0.000857	CcSEcCtD
Levetiracetam—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000344	0.000846	CcSEcCtD
Levetiracetam—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000344	0.000844	CcSEcCtD
Levetiracetam—Skin disorder—Methotrexate—lymphatic system cancer	0.000341	0.000838	CcSEcCtD
Levetiracetam—Anorexia—Methotrexate—lymphatic system cancer	0.000335	0.000822	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00032	0.000786	CcSEcCtD
Levetiracetam—Insomnia—Methotrexate—lymphatic system cancer	0.000318	0.00078	CcSEcCtD
Levetiracetam—Paraesthesia—Methotrexate—lymphatic system cancer	0.000315	0.000774	CcSEcCtD
Levetiracetam—Somnolence—Methotrexate—lymphatic system cancer	0.000312	0.000767	CcSEcCtD
Levetiracetam—Dyspepsia—Methotrexate—lymphatic system cancer	0.000309	0.000759	CcSEcCtD
Levetiracetam—Decreased appetite—Methotrexate—lymphatic system cancer	0.000305	0.00075	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000303	0.000745	CcSEcCtD
Levetiracetam—Fatigue—Methotrexate—lymphatic system cancer	0.000303	0.000743	CcSEcCtD
Levetiracetam—Pain—Methotrexate—lymphatic system cancer	0.0003	0.000737	CcSEcCtD
Levetiracetam—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000289	0.000711	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000287	0.000705	CcSEcCtD
Levetiracetam—Abdominal pain—Methotrexate—lymphatic system cancer	0.000278	0.000682	CcSEcCtD
Levetiracetam—Body temperature increased—Methotrexate—lymphatic system cancer	0.000278	0.000682	CcSEcCtD
Levetiracetam—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000259	0.000635	CcSEcCtD
Levetiracetam—Asthenia—Methotrexate—lymphatic system cancer	0.000252	0.000619	CcSEcCtD
Levetiracetam—Pruritus—Methotrexate—lymphatic system cancer	0.000248	0.00061	CcSEcCtD
Levetiracetam—Diarrhoea—Methotrexate—lymphatic system cancer	0.00024	0.00059	CcSEcCtD
Levetiracetam—Dizziness—Methotrexate—lymphatic system cancer	0.000232	0.00057	CcSEcCtD
Levetiracetam—Vomiting—Methotrexate—lymphatic system cancer	0.000223	0.000548	CcSEcCtD
Levetiracetam—Rash—Methotrexate—lymphatic system cancer	0.000221	0.000544	CcSEcCtD
Levetiracetam—Dermatitis—Methotrexate—lymphatic system cancer	0.000221	0.000543	CcSEcCtD
Levetiracetam—Headache—Methotrexate—lymphatic system cancer	0.00022	0.00054	CcSEcCtD
Levetiracetam—Nausea—Methotrexate—lymphatic system cancer	0.000209	0.000512	CcSEcCtD
